سعر استيرو-ماب 10مجم 30 قرص 2025

Rosuvastatin 10 mg film-coated tablets, 30 tablets (Multi-Apex).

• Adjunct to diet to reduce LDL-C in adults with primary hyperlipidemia, and in paediatric patients with familial hypercholesterolemia; also hypertriglyceridemia and primary dysbetalipoproteinemia in adults.Population: Adults; paediatric familial hypercholesterolemiaDailyMed (U.S. National Library of Medicine)
• To reduce the risk of major adverse cardiovascular events in adults without established coronary heart disease who are at increased risk of cardiovascular disease.Population: AdultsDailyMed (U.S. National Library of Medicine)

• Most frequent adverse reactions (2% or more): headache, nausea, myalgia, asthenia and constipation.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Acute liver failure or decompensated cirrhosis; hypersensitivity to rosuvastatin or any excipient.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Myopathy and rhabdomyolysis: risk factors include age 65 years or older, uncontrolled hypothyroidism, renal impairment, certain concomitant drugs and higher doses; Asian patients may be at higher risk. Discontinue if markedly elevated CK occurs or myopathy is diagnosed or suspected. Hepatic dysfunction, proteinuria/hematuria and increases in HbA1c and fasting glucose have also been reported.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• CyclosporineDo not exceed rosuvastatin 5 mg once daily.DailyMed (U.S. National Library of Medicine)
• GemfibrozilAvoid concomitant use; if unavoidable, start at 5 mg once daily and do not exceed 10 mg once daily (increased myopathy risk).DailyMed (U.S. National Library of Medicine)
• WarfarinObtain INR before starting rosuvastatin and monitor frequently until stable after initiation, titration or discontinuation.DailyMed (U.S. National Library of Medicine)

• Discontinue rosuvastatin when pregnancy is recognized; alternatively consider the ongoing therapeutic needs of the individual patient. It may cause fetal harm based on its mechanism of action.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Breastfeeding is not recommended during treatment with rosuvastatin.International label, same formulation · DailyMed (U.S. National Library of Medicine)

English text not available for this section.